Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique.
about
PARACEST MRI with improved temporal resolutionPractical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationWater exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.Steady-state and dynamic contrast MR imaging of human prostate cancer xenograft tumors: a comparative study.Congruent MRI and near-infrared spectroscopy for functional and structural imaging of tumors.Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate.Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and ExamplesChanges in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat gliomaTumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in miceNoninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.The role of heparanase in lymph node metastatic dissemination: dynamic contrast-enhanced MRI of Eb lymphoma in mice.Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.MRI for assessing antivascular cancer treatments.Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT.Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRIMR imaging biomarkers for evaluating therapeutic effects shortly after near infrared photoimmunotherapy.Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.Challenges in the development of magnetic particles for therapeutic applications.Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.Assessment of myocardial perfusion using contrast-enhanced MR imaging: current status and future developments.Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme.Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors.Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics.MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology.Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma.Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model.A cell- surface polymer reptation mechanism for tumor transendothelial transport of macromolecules.Non-invasive quantification of anti-angiogenic therapy by contrast-enhanced MRI in experimental pancreatic cancer.Applications of dynamic contrast enhanced MRI in oncology: measurement of tumor oxygen tension.Lectin-Gd-loaded chitosan hydrogel nanoparticles: a new biospecific contrast agent for MRIAssessing permeability alterations of the blood-bone marrow barrier due to total body irradiation: in vivo quantification with contrast enhanced magnetic resonance imaging
P2860
Q28833643-7A257E09-8132-4A85-8739-750D5B9ECEB3Q30575110-B5D3E390-E34E-48A8-AD8C-2C17C0F9694CQ30651989-764C69D7-FE2A-4134-8ED4-C4C298893663Q30775286-CFE21976-0F19-45A9-91BC-4651B6AD4B9EQ30775295-58148B82-65AC-41B4-9E04-55E371190AE1Q33347186-C055ABF6-7DDC-4006-87A8-53E2BBD912E9Q33369337-64850282-CB3D-4855-B223-33BBD12F6FA8Q33486630-F43EE33E-8047-4F76-A891-A7FF9B98185DQ33510695-C8B8A722-904A-4038-9B41-2BA6EEB0B5C5Q33525581-6CBB5454-CD92-4972-8613-0AC53055C849Q33584677-5B6A2D07-6416-45BE-8354-D17E707AC304Q33625077-638997C2-DF37-4DB8-AD68-B319BAA7F325Q33847006-E6F6340D-E316-46CB-88DF-674988200356Q33973363-AFCBF65D-F82B-4FC4-AE59-512FA77900DAQ34768370-321C009E-FED4-4CDB-BE1A-392B339E5050Q34918635-49557C7E-D4FC-4173-842B-1D05C8D1E249Q35402503-083FE3BD-2C78-4456-93F9-C038B6223C38Q35581064-D7B4AE83-53B8-4291-A523-864CDBC9AA85Q35905005-7044A70D-CE9A-4D82-8B87-3E2A017C7859Q36484980-121EA364-6525-4607-8AFA-E2798A2859A6Q36976713-DEFF37F9-0565-48AF-953F-8BD89C0B9C9FQ37086258-3E307BC8-3780-41D6-82EE-B8DB6566F096Q37113814-396A22CF-FB8C-4905-BB8A-1CAC00DD04C6Q37209899-D4C5D61A-B0EC-44D6-B5CC-CF928E32CBB2Q37417880-6F86D46C-CED1-4C1D-843F-1D76283F6FFDQ40438139-7269C8CC-4064-482B-9A52-99841688C773Q40744900-4B0A665C-C08A-4CF7-8371-6FEAFB0E7E36Q41609320-8ED2A826-18E4-467E-B0BA-A813993CDCC5Q41613336-930C298A-8AFB-42C6-951E-F71239691B5AQ41742671-9ED7E08A-B4E7-496E-9DF3-BD1E949ADC81Q46089577-86E66E5A-FC80-461F-8661-4FB24A769292Q46103337-57312AE3-4AC6-4017-A022-F13F4DFAD05EQ46298694-A663B548-AE97-46FC-8402-BB52AD61C929Q46319983-40C3F45C-F489-4826-838A-8701A6B0C9F7Q46595419-A9564F33-E245-4B8F-8F7F-46DBBEF73DB6Q46600243-10DCB2FF-2FA6-4B44-870C-5D34CFDC5E3AQ47920335-B4321824-4939-4F2C-B6F2-D9751A94CB0CQ52021449-39FE4F04-ECA3-4D19-891F-53A9B65E2C8BQ57185335-91BA8B6D-7937-43EB-A6E7-500252999A00Q57188857-CA4A01F5-B178-4E09-967A-B374CB073092
P2860
Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Measurement of capillary perme ...... itative noninvasive technique.
@en
type
label
Measurement of capillary perme ...... itative noninvasive technique.
@en
prefLabel
Measurement of capillary perme ...... itative noninvasive technique.
@en
P2093
P2860
P356
P1476
Measurement of capillary perme ...... itative noninvasive technique.
@en
P2093
P2860
P304
P356
10.1002/MRM.1910290506
P577
1993-05-01T00:00:00Z